PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,000 | -50.0% | 352 | -47.2% | 0.00% | – |
Q1 2020 | $2,000 | -50.0% | 667 | -51.8% | 0.00% | – |
Q4 2019 | $4,000 | -55.6% | 1,385 | -67.4% | 0.00% | -100.0% |
Q3 2019 | $9,000 | -10.0% | 4,246 | +35.9% | 0.00% | 0.0% |
Q2 2019 | $10,000 | -16.7% | 3,125 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $12,000 | +50.0% | 3,125 | +6.8% | 0.00% | 0.0% |
Q4 2018 | $8,000 | 0.0% | 2,925 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $8,000 | +166.7% | 2,925 | +111.2% | 0.00% | – |
Q2 2018 | $3,000 | – | 1,385 | +5921.7% | 0.00% | – |
Q4 2014 | $0 | – | 23 | 0.0% | 0.00% | – |
Q3 2014 | $0 | – | 23 | 0.0% | 0.00% | – |
Q2 2014 | $0 | -100.0% | 23 | -94.9% | 0.00% | -100.0% |
Q1 2014 | $4,000 | – | 448 | +1847.8% | 0.00% | – |
Q4 2013 | $0 | – | 23 | 0.0% | 0.00% | – |
Q3 2013 | $0 | – | 23 | 0.0% | 0.00% | – |
Q2 2013 | $0 | – | 23 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KESTREL INVESTMENT MANAGEMENT CORP | 1,634,000 | $4,804,000 | 1.81% |
SMH CAPITAL ADVISORS INC | 80,722 | $237,000 | 0.37% |
Matarin Capital Management, LLC | 1,126,641 | $3,312,325,000 | 0.25% |
Hillsdale Investment Management Inc. | 337,800 | $993,000 | 0.14% |
Zebra Capital Management LLC | 115,431 | $339,000 | 0.12% |
Connor, Clark & Lunn Investment Management Ltd. | 4,789,702 | $14,082,000 | 0.08% |
Fortis Advisors, LLC | 45,602 | $134,000 | 0.07% |
Municipal Employees' Retirement System of Michigan | 500,080 | $1,470,000 | 0.07% |
RBF Capital, LLC | 173,090 | $508,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 392,276 | $1,153,000 | 0.06% |